Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)

Phase 4

Completed

• Conditions: Renal Disorder

• Registration Number: NCT00140985
• Lead Sponsor: Organon and Co

Brief Summary

Antiproteinuric Efficacy of Losartan Potassium in Patients with Non-Diabetic Proteinuric Renal Diseases.

Detailed Description

Not available

Study Timeline

• Study Start: 2000-02
• Primary Completion: 2002-01
• Study Completion: 2002-01
• Study First Submitted: 2005-08-30
• Study First Submitted QC: 2005-08-30
• Study First Posted: 2005-09-01
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-04
• Last Update Posted: 2022-02-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 97

Inclusion Criteria

• Males or females at least 18 years of age with non-diabetic proteinuric renal diseases

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
24h proteinuria

Secondary Outcome Measures

Name	Time	Method
Changes in the plasma and urinary levels of TGF-beta